INTERNATIONAL PATENT: GILEAD SCIENCES, INC. FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING BULEVIRTIDE AND LONAFARNIB FOR USE IN THE TREATMENT OF HEPATITIS D VIRUS INFECTION"

GENEVA, Nov. 25 -- GILEAD SCIENCES, INC. (333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2025/028573) for "COMBINATION THERAPIES COMPRISING BULEVIRTIDE AND LONAFARNIB FOR USE IN THE TREATMENT OF HEPATITIS D VIRUS INFECTION" on May 09, 2025. With publication no. WO/2025/240244, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FLETCHER, Simon P. (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404), HOLDORF, Meghan M. (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster ...